Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Binder

Showing results (261-270 of 653) with videos related to

Pageof 66
Sort By:
Wiener Klinische Wochenschrift|March 21, 1998
Myotonic dystrophy: molecular genetics and diagnosisE Gharehbaghi-Schnell, J Finsterer, I Korschineck, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1982
Determinants of drug treatment maintenance among hypertensive persons in inner city DetroitK M Cummings, J P Kirscht, L R Binder, et al.
European Urology|January 1, 1988
Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinomaG Hienert, J C Kirchheimer, G Christ, et al.
European Journal of Biochemistry|July 15, 1987
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activatorJ C Kirchheimer, I Resch, G Christ, et al.
Neuroimage|May 17, 2005
Volumetric vs. surface-based alignment for localization of auditory cortex activationRutvik Desai, Einat Liebenthal, Edward T Possing, et al.
European Journal of Clinical Investigation|December 1, 1988
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluidK Huber, J Wojta, J C Kirchheimer, et al.
Molecular Biology of the Cell|November 28, 2008
Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptorHerbert B Schiller, Andreas Szekeres, Bernd R Binder, et al.
Neuroimage|November 5, 2005
Interrupting the "stream of consciousness": an fMRI investigationKristen A McKiernan, Benjamin R D'Angelo, Jacqueline N Kaufman, et al.
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinaseJ Wojta, J C Kirchheimer, L Turcu, et al.
Cancer Research|April 1, 1992
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoproteinK Huber, J C Kirchheimer, D Ermler, et al.
Pageof 66

Showing results (261-270 of 653) with videos related to

Sort By:
Pageof 66
Wiener Klinische Wochenschrift|March 21, 1998
Myotonic dystrophy: molecular genetics and diagnosisE Gharehbaghi-Schnell, J Finsterer, I Korschineck, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1982
Determinants of drug treatment maintenance among hypertensive persons in inner city DetroitK M Cummings, J P Kirscht, L R Binder, et al.
European Urology|January 1, 1988
Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinomaG Hienert, J C Kirchheimer, G Christ, et al.
European Journal of Biochemistry|July 15, 1987
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activatorJ C Kirchheimer, I Resch, G Christ, et al.
Neuroimage|May 17, 2005
Volumetric vs. surface-based alignment for localization of auditory cortex activationRutvik Desai, Einat Liebenthal, Edward T Possing, et al.
European Journal of Clinical Investigation|December 1, 1988
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluidK Huber, J Wojta, J C Kirchheimer, et al.
Molecular Biology of the Cell|November 28, 2008
Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptorHerbert B Schiller, Andreas Szekeres, Bernd R Binder, et al.
Neuroimage|November 5, 2005
Interrupting the "stream of consciousness": an fMRI investigationKristen A McKiernan, Benjamin R D'Angelo, Jacqueline N Kaufman, et al.
Thrombosis and Haemostasis|June 30, 1986
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinaseJ Wojta, J C Kirchheimer, L Turcu, et al.
Cancer Research|April 1, 1992
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoproteinK Huber, J C Kirchheimer, D Ermler, et al.
Pageof 66